Early Access — free while we kick the tires
EdgarHawk

Mani Mohindru

Chief Executive Officer

Director Officer

Latest: CEO buying · June 2026

1 filing analyzed · 1 company · Latest 2026-06-22

Companies

Company Buys Sells Direction
Cardiff Oncology, Inc. CRDF 1 0 Net buying

Activity

June 2026
2026-06-22 Cardiff Oncology, Inc. CRDF
medium
Buy
24,703 shares
$29,891
Significance 4/10

CEO Mani Mohindru purchases 24,703 shares of CRDF at $1.21 amid -73.5% decline from 52-week high

Mani Mohindru, Chief Executive Officer, acquired 24,703 shares at $1.21 on 2026-06-18, increasing his holdings from 0 to 24,703 shares. The purchase occurs after the stock has declined -73.5% from its 52-week high of $4.56, and the company has contracted by -13.2% in annual revenue while posting a net loss of $-12.3M in its most recent fiscal year. This represents the CEO's initial stock position. The transaction occurs in a context of significant stock price weakness and ongoing operational losses, but the limited position size (24.7K shares out of an $82.7M market cap) and recent price momentum (down -31.2% in 30 days and -32.8% in 90 days) provide limited basis for inferring conviction at this level.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access